WT1 and acute myeloid leukemia: We thus could not perform a focused analysis in determined subgroups to assess the prognostic role of WT1 mutation in each ELN 2022 category and within specific genetic subgroups, such as NPM1-mutated or bZIP-mutated CEBPA AML.